Depression Screening: What a Positive Questionnaire Result Means
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
A positive depression screening result means that the answers on a brief questionnaire crossed a threshold that warrants further discussion and assessment. It identifies a possibility of depression or clinically relevant depressive symptoms; it does not establish major depressive disorder, describe a complete psychiatric history, or determine which treatment a person needs. The next step is a conversation with a qualified health professional who evaluates symptoms, timing, functioning, safety, and possible alternative explanations. U.S. Preventive Services Task Force; NICE NG222.
This distinction is essential whether the screen was completed at a primary care visit, an annual physical, a university counseling center, a workplace health program, a hospital, or an online questionnaire. The information may be useful even when a person does not meet the criteria for a depressive disorder. It may also point to something requiring more immediate attention, particularly if an answer concerns death or self-harm. A good screening pathway turns a brief signal into an appropriate clinical conversation.
I. What Does a Positive Depression Screen Actually Mean?
Depression screening is an early identification procedure. A questionnaire asks about experiences commonly associated with depression, usually over a defined recent period, and compares the responses with a predetermined scoring or decision rule. A positive result means that this rule has been met. The rule is designed to help decide who should receive further evaluation. Its statistical meaning depends on the specific instrument, cutoff, population, and clinical setting. USPSTF recommendation.
The result makes a statement about answers to questions, not about a confirmed disease. Someone may score above a screening threshold because of a major depressive episode, persistent depressive symptoms, an anxiety disorder, insomnia, an illness that affects energy or concentration, a difficult life period, or overlapping conditions. Another person with a depressive disorder may score below a threshold. Both possibilities are built into the limits of screening instruments. USPSTF evidence summary; AAP GLAD-PC.
1. Four decisions that must remain separate
A depressive symptom is an experience such as anhedonia, low energy, disrupted sleep, hopelessness, or low mood. A positive screen identifies a pattern of questionnaire responses. A clinical diagnosis is a professional conclusion based on diagnostic criteria and a broader evaluation. A treatment decision considers the diagnosis or clinical formulation, severity, patient preferences, prior response, possible harms, access, and safety. These steps are connected, but each answers a different question. For a complete diagnosis-focused explanation, see Depression Diagnosis: What a Clinical Evaluation Includes.
A person can have genuine and impairing symptoms without satisfying the full criteria for major depressive disorder. Such symptoms still deserve attention. Conversely, a seemingly mild score cannot exclude an urgent concern if the person describes suicidal intent, psychosis, severe deterioration, or unusual periods of elevated mood. The clinical context determines what must happen next.
II. Which Depression Questionnaires Are Commonly Used?
Several tools are used in health care, and their names are sometimes mistaken for diagnoses. The Patient Health Questionnaire-2 (PHQ-2) is a brief initial screen focused on depressed mood and loss of interest. The Patient Health Questionnaire-9 (PHQ-9) asks about nine symptom domains and is widely used in adults. Other population-specific tools include the Geriatric Depression Scale and, in perinatal settings, the Edinburgh Postnatal Depression Scale. Selection depends on the setting and the person being evaluated. USPSTF.
The PHQ-9 asks about symptoms experienced during the previous two weeks. The sum commonly ranges from 0 to 27. A cutoff of 10 or more is often used as a positive screen for major depression in research and clinical settings, but it is not a universal diagnostic boundary. Some services employ the PHQ-2 as a preliminary step and administer the PHQ-9 only when the shorter screen is positive. Others use scores to monitor symptoms over time after clinical assessment. Levis et al., BMJ individual participant data meta-analysis.
The threshold should be interpreted alongside the precise version of the questionnaire, its intended purpose, administration conditions, age group, language validation, and the clinician's judgment. A health service can use a different threshold when prioritizing sensitivity or specificity. A score collected for monitoring a patient already diagnosed with depression is conceptually different from a screening result obtained in a person without a recognized condition. Detailed psychometrics, individual items, validation studies, and score interpretation belong to the separate English Hub PHQ-9 instrument topic.
1. What does a PHQ-9 score of 10 or higher mean?
In many adult screening settings, a PHQ-9 score at or above 10 indicates that a follow-up evaluation is appropriate. It does not imply a ten-out-of-ten severity judgment, a 100% probability of depression, a particular treatment requirement, or proof of a major depressive episode. In a major individual-participant-data meta-analysis, a cutoff of 10 had pooled sensitivity of approximately 88% and specificity of approximately 85% against semistructured diagnostic interviews, with variation across studies and reference standards. Levis et al., 2019.
The PHQ-9 is also used to describe symptom burden by conventional score bands. Those labels summarize questionnaire response intensity rather than replacing a clinician's assessment of actual illness severity. A person with a low total score may have a serious risk issue, and a person with a high score may have conditions or circumstances that require a different diagnostic explanation.
2. What if the score is below the cutoff?
A negative screen lowers concern under the test's decision rule but does not rule out depression. People may underreport symptoms because of privacy concerns, shame, differences in how questions are understood, memory, or fluctuating symptoms. Some forms of impairment do not fit neatly into a two-week questionnaire window. Clinicians should evaluate persistent symptoms, changes in functioning, or concerning clinical signs even when a screening result is negative. Adolescent guidance explicitly recommends assessment when depression is strongly suspected despite a negative screen. AAP GLAD-PC.
III. Why Is a Positive Screen Not the Same as a Diagnosis?
A diagnostic evaluation asks whether the entire pattern meets criteria for a particular depressive disorder and whether other explanations better account for the symptoms. It considers onset, duration, core symptoms, total symptom constellation, clinical distress, impairment, recurrence, previous episodes, medical contributors, and conditions that may coexist with depression. NICE recommends a comprehensive assessment instead of relying simply on symptom counting. NICE NG222.
For a major depressive episode, clinicians assess a sustained change over at least two weeks with either depressed mood or loss of interest or pleasure and other characteristic symptoms, together with clinically significant distress or impairment. They also review exclusions and differentials. Major depressive disorder additionally requires a history and course consistent with a unipolar depressive condition, including attention to past mania or hypomania. A questionnaire alone cannot adequately establish these features. NIMH depression overview; VA/DoD clinical guideline.
Screening a population without known depression also differs from evaluating a person who seeks treatment because their symptoms are already apparent. In the former situation, the tool aims to identify possible unrecognized cases. In the latter, the clinical interview may already be indicated regardless of the questionnaire. That difference changes how useful the word 'positive' is.
IV. False Positives, False Negatives, and What Test Accuracy Really Means
A false-positive screen is a result above the chosen threshold in a person who does not meet the target diagnosis on the reference clinical assessment. It is a test classification, not proof that the person's distress is imagined. An individual may have clinically important anxiety, sleep problems, chronic pain, adjustment difficulties, subthreshold depression, or another condition requiring care. A false negative means the screen is below the threshold despite the target condition being present. These outcomes are unavoidable when a brief score is used to approximate a multifaceted diagnosis.
1. Why the proportion of true cases matters
Sensitivity describes the proportion of people with the target disorder who screen positive; specificity describes the proportion without the disorder who screen negative. The proportion of positive results that correspond to the disorder is called positive predictive value. That proportion depends strongly on how common the disorder is in the tested group. Therefore, identical questionnaires and thresholds can produce different meanings for a positive result in different settings. Levis et al., 2019.
In one major PHQ-9 meta-analysis, among studies using semistructured interviews, the proportion with major depression was about 14%. At the cutoff of 10, the estimated positive predictive value was approximately 49% in that dataset; around half of positive screens did not meet the major-depression reference diagnosis. This is a study-specific illustration, not a probability assigned to any individual reader. It explains why clinical follow-up is essential and why a screening result should neither be dismissed nor treated as confirmed disease. Original analysis in BMJ.
2. What changes the accuracy of screening?
Questionnaire performance can change with baseline prevalence, language and cultural context, age, clinical setting, coexisting medical conditions, question format, cutoff, and the reference interview used to define a case. Online questionnaires administered without a clinician also differ from structured screening embedded in a health-care service. The PHQ-9 accuracy review found that the reference interview method affected estimated sensitivity. Test characteristics should never be transferred mechanically from one population to another. Levis et al., 2019.
A questionnaire also describes a moment in time. A person may complete it during a temporary worsening, after a sleepless week, during recovery, or at the onset of a persistent episode. Longitudinal information, the clinician's interview, and sometimes reassessment clarify the meaning of the initial score.
V. What Happens After a Positive Depression Screening Result?
A positive screen should trigger a defined follow-up pathway. The U.S. Preventive Services Task Force recommends adult depression screening in health systems equipped to provide accurate diagnosis, treatment or referral, and appropriate follow-up. It specifically states that positive results require additional assessment to confirm diagnosis, establish severity, and identify coexisting problems. Screening without a pathway for follow-up can fail to deliver its intended benefit. USPSTF, 2023.
1. A conversation about the result
A clinician should explain which questionnaire was administered, the period it covers, the cutoff used, and what the result suggests. The person can describe which questions matched their experience, which did not, and what prompted them to answer as they did. They should be able to clarify uncertain responses. An online result can be brought to a primary care appointment or mental health consultation even if the questionnaire was completed outside a clinical service.
2. Evaluation of symptoms and functioning
Follow-up normally includes questions about low mood, pleasure, fatigue, sleep, appetite, attention, guilt or worthlessness, slowed or restless movement, hopelessness, and thoughts of death, together with how long these experiences have lasted and how they affect work, study, relationships, self-care, and ordinary activities. Clinicians ask about recent stressors and existing sources of support, then evaluate symptoms in their personal and medical context. NICE comprehensive assessment.
3. Review of medical and psychiatric context
Depending on the case, the evaluation may address a history of depressive episodes, chronic depressive symptoms, manic or hypomanic experiences, anxiety, trauma, substance or alcohol use, sleep disorders, medications, and medical conditions. Physical examination or targeted laboratory tests may be appropriate when the history suggests a relevant medical contributor. There is no single blood test that verifies or excludes major depressive disorder. For the broader symptom landscape, see Depression Symptoms: Emotional, Physical, and Behavioral Signs.
4. Safety and urgency
A clinician should determine whether immediate safety concerns exist, including suicidal thoughts, self-harm, inability to care for basic needs, psychotic symptoms, or severe agitation. The presence of a risk-related answer changes the urgency of the pathway independently of the overall depression score. A positive response on the PHQ-9's item concerning death or self-harm calls for prompt direct assessment of the person's experience and current safety. The item is not, on its own, a validated suicide-risk screen or a prediction of an attempt. AAP suicide-risk guidance; NIMH ASQ toolkit.
5. A documented plan
The next step may be an additional interview, an appointment with primary care or behavioral health, a referral for diagnostic assessment, a safety evaluation, symptom monitoring, discussion of psychosocial needs, or treatment after evaluation. The plan should name who will follow up and how the person can obtain help if symptoms worsen. It is reasonable for a patient to ask when to expect contact and what to do if no appointment is offered. USPSTF recommendation.
VI. Do I Need Treatment Because My Questionnaire Is Positive?
A positive score alone does not mandate medication, psychotherapy, hospitalization, or any other intervention. Treatment follows a clinical assessment and shared discussion of goals, symptom persistence, impairment, clinical diagnosis where established, preferences, contraindications, prior treatment, and access. Some people need prompt specialized care; some need a structured follow-up and support plan; others benefit from treatment for a different primary problem. NICE NG222; VA/DoD guideline.
When a depressive disorder is confirmed, evidence-based care may include psychotherapy, medication, or a combination, depending on presentation and severity. Selecting among them is a separate clinical question. The English Hub's Depression Treatment: Therapy, Medication, and Other Options discusses treatment pathways, benefits, and shared decisions. A questionnaire score should never be used as an automatic prescription instruction, nor should someone start, stop, or change prescribed medication on the basis of an online screen.
VII. What if the Result Was From an Online Depression Test?
An online questionnaire may reproduce questions from a validated screening tool, but the quality of the experience also depends on whether the wording, response scale, scoring, population, language, and interpretation are faithful to its validation. Some internet tests use unvalidated questions or attach definitive labels to a score. A web page that reports 'you have depression' after several clicks makes a stronger claim than the underlying screening evidence supports.
If the questionnaire identifies itself, note its name, date, recall period, your responses, and how you felt when taking it. If it is anonymous or cannot explain its scoring, treat its diagnostic claims particularly cautiously. A clinician can ask about the experiences that prompted the test even when its numerical result is unreliable. Privacy matters as well: avoid sharing sensitive responses with services whose data practices you cannot understand.
Taking the same test repeatedly over short periods is rarely a substitute for assessment. Scores may fluctuate, and repeated checking can become a source of anxiety without yielding a clear plan. A better next step is to discuss persistent symptoms, bring the results to an appropriate professional, and agree on whether and when repeated measurement is useful.
VIII. When the Result Points to Something Other Than Unipolar Depression
Depression-like symptoms are transdiagnostic: they can appear across many clinical conditions and ordinary experiences. A screen should therefore open an assessment rather than force all answers into one explanation. A structured differential evaluation considers whether the symptom course and accompanying features suggest a depressive condition, an anxiety disorder, a reaction to a life event, a sleep or medical disorder, the effects of a substance, or overlapping problems. NICE NG222.
1. Bipolar disorder and a history of elevated mood
Someone presenting with low mood may also have experienced distinct past periods of unusually elevated or irritable mood, decreased need for sleep, increased energy, accelerated activity, or other features of hypomania or mania. Such history matters because the treatment approach for bipolar depression differs from that for unipolar major depressive disorder. Depression screening questionnaires are not designed to exclude bipolar disorders. The clinical interview should ask about these episodes before establishing a unipolar diagnostic pathway. NICE assessment recommendations.
2. Anxiety, obsessive-compulsive symptoms, and other coexisting problems
Anxiety can contribute to poor sleep, fatigue, indecision, concentration problems, and withdrawal; it also commonly co-occurs with depression. A positive depression screen may therefore lead to assessment for both. For specific overlaps, see Anxiety and Depression: Why They Commonly Co-Occur and OCD and Depression: What Is the Connection?. These linked conditions retain their own diagnostic and editorial pathways.
3. Grief, burnout, medical conditions, and medication effects
Bereavement, occupational exhaustion, chronic pain, sleep apnea, thyroid dysfunction, medication adverse effects, and substance use can all be relevant to the clinical discussion. Each has its own diagnostic or contextual framework, and they may coexist with a depressive disorder. It would be inappropriate to infer one of these causes from the questionnaire alone or to assume they automatically exclude depression. A careful evaluation asks what preceded the symptoms, how they behave over time, and whether independent clinical criteria are met. NIMH depression overview; NICE NG222.
IX. Special Considerations in Children, Teenagers, and Older Adults
1. Adolescents
Young people may experience depressive symptoms through irritability, school difficulties, sleep disruption, loss of interest, family conflict, changes in appetite, or social withdrawal. The American Academy of Pediatrics' GLAD-PC guidance recommends annual depression screening from age 12 in primary care and direct clinical evaluation after a positive screen. It emphasizes that questionnaires alone yield false positives and false negatives and that diagnosis requires a developmentally appropriate interview, attention to impairment, and additional information where appropriate. The 2018 guidance was reaffirmed in 2025. AAP GLAD-PC.
Privacy, consent, youth participation, and the safety of involving caregivers require judgment. Clinicians commonly speak with adolescents privately and assess safety while considering family involvement and local laws. A questionnaire result reported by a parent is not a substitute for hearing directly from the teenager. A child or teen describing current self-harm thoughts needs a prompt safety assessment regardless of the total questionnaire score. AAP adolescent suicide-risk report.
2. Older adults
For an older adult, fatigue, sleep changes, cognitive complaints, physical illness, grief, medication effects, and functional limitations can affect the screening picture. Screening can be useful, but the follow-up interview must examine medical context, current functioning, and the person's own account. The USPSTF adult depression-screening recommendation includes adults age 65 and older. Population-specific instruments may be considered when appropriate. USPSTF.
3. Disability, language, and accessibility
Communication needs may affect responses to questions about concentration, activity, or social engagement. When a person uses a different language, has a sensory or cognitive disability, or needs alternative communication, assessment should be adapted and a validated form used where available. Clinicians should prioritize understanding the actual experience rather than assigning a confident meaning to a score obtained with an unsuitable version. NICE explicitly recommends appropriate communication methods for people with language or communication difficulties. NICE NG222.
X. What if the Questionnaire Mentions Death or Self-Harm?
Depression screening and suicide-risk assessment are distinct clinical tasks. The PHQ-9 includes an item about thoughts of being better off dead or hurting oneself, but that single item does not establish intention, a plan, imminence, or an individual's future risk. A positive response requires a timely direct conversation and appropriate further assessment. A negative item also does not prove that the person has no suicide risk. The AAP specifically warns against treating PHQ-9 item 9 as a suicide-risk screening tool. AAP clinical report.
Trained clinicians may use a separate validated suicide-risk screening approach and, after a positive result, conduct a brief suicide safety assessment. NIMH's Ask Suicide-Screening Questions toolkit provides setting-specific pathways for clinical teams. The correct response depends on present thoughts, intent, access to means, prior behavior, protective factors, and the person's situation, not on a numeric depression total alone. NIMH ASQ toolkit.
If you are in immediate danger, believe you might act on thoughts of suicide, or cannot stay safe, seek emergency help now. In the United States call emergency services or contact the 988 Suicide & Crisis Lifeline by calling or texting 988. Elsewhere use your local emergency or crisis service. A trusted person can help you reach in-person support and remain with you while urgent help is arranged. NIMH adult suicide-screening resources.
XI. How Soon Should You Seek Follow-Up?
A nonurgent positive depression screen warrants a timely appointment with a qualified clinician, particularly when symptoms are persistent or disrupting life. The exact interval depends on symptom severity, clinical setting, current supports, access, and safety, rather than on a fixed score-to-days rule. Contact the service that administered the screen, your primary care practice, or an appropriate mental health professional, and ask what follow-up arrangement has been made.
Seek more immediate assessment when symptoms are rapidly worsening, ordinary self-care becomes difficult, there are symptoms suggesting mania or psychosis, or concerns arise about self-harm or suicide. In an emergency, use emergency services. Even a score below the formal cutoff should not delay clinical discussion when significant warning signs are present. NICE NG222; NIMH ASQ.
XII. What to Bring to a Depression Follow-Up Appointment
Useful preparation includes the exact questionnaire name, score and date; which symptoms are affecting you most; approximately when they started; changes in work, school, daily routines and relationships; sleep and substance use; current medications; past mood or anxiety episodes; treatment experiences; medical diagnoses; and any concerns about safety. You may bring the actual responses if sharing them feels helpful. These details support a more precise conversation than the total score alone.
Questions worth asking include: Which diagnosis, if any, is currently supported? What other explanations should we consider? Is my condition urgent? Do I need a more detailed interview or medical tests? What treatment and support options fit my circumstances? Who will contact me, and when? What should I do if my symptoms worsen? You can ask a clinician to explain uncertainty and revisit a provisional formulation if new information appears.
XIII. What Happens if the Clinical Assessment Does Not Confirm Major Depression?
A negative diagnostic evaluation after a positive screen does not retroactively erase the symptoms that prompted the questionnaire. It means the clinician did not find sufficient evidence for the specific diagnosis at that time. They may identify another depressive condition, symptoms below the diagnostic threshold, a coexisting anxiety problem, a medical cause, or a need for monitoring as the clinical picture develops. A relevant plan can still include support, follow-up, or referral.
If the clinical explanation seems incomplete, ask how the diagnosis was evaluated and what changes would justify a reassessment. Clinicians may need additional information about symptoms over time or their effect on functioning. The objective is a useful and revisable clinical account, rather than making the person fit a label.
XIV. Using Screening Scores Over Time
After an evaluation, repeated questionnaires can provide structured information about symptom change and help clinicians discuss response to care. A falling score may be consistent with improvement, and a rising score may prompt reassessment, but meaningful recovery also involves functioning, safety, patient goals, and sustained change. Symptom scales do not independently define remission, relapse, recurrence, or treatment-resistant depression. The timing and interpretation of measurement should form part of a clinician-guided plan. NICE NG222.
A screening score taken at the first visit, a follow-up measurement during treatment, and a diagnostic assessment represent different types of information. Clear documentation should preserve which tool was used, its date, whether the person was already receiving treatment, and what decisions followed.
XV. Does Depression Screening Help People?
Screening can identify people who might otherwise go unrecognized, but its benefits depend on systems that connect positive results to assessment, evidence-based treatment when indicated, and follow-up. The USPSTF's 2023 recommendation assigned adult depression screening a B grade and emphasized adequate systems for diagnosis and treatment. Its review found evidence favoring screening programs, many of which included additional care-management elements; it also described limits of the available trials and the difficulty of isolating screening from the services accompanying it. USPSTF recommendation; USPSTF evidence review.
For an individual, the strongest practical use of a screening result is to make clinically relevant symptoms visible, start an informed conversation, and establish what happens next. The screen achieves its purpose when the person can move from a numerical result to meaningful assessment and care.
XVI. Frequently Asked Questions
1. Does a positive depression screen mean I have major depressive disorder?
No. It means your answers met a defined screening rule. A qualified clinician must assess whether diagnostic criteria are met and whether another condition better explains the symptoms. USPSTF.
2. Is a PHQ-9 score of 10 a diagnosis?
No. Ten is a commonly used screening cutoff in adults, supported by diagnostic-accuracy research, but the score cannot independently establish a diagnosis. BMJ meta-analysis.
3. What if I score high but feel that I am doing fine?
Describe that discrepancy during follow-up. A score may capture genuine symptoms while missing your sense of functioning, or may reflect influences unrelated to major depression. The assessment should ask about distress, impairment, medical and life context, and the particular answers that drove the total.
4. Can a positive screen be wrong?
Yes, as a predictor of the target diagnosis. False-positive and false-negative results occur with all screening thresholds. A false-positive classification can coexist with real symptoms that warrant care. BMJ meta-analysis.
5. Should I repeat the test tomorrow?
Usually the more informative next step is to arrange follow-up and discuss why the result was positive. A repeat test may be useful at an agreed interval, but repeated daily scores may simply reflect ordinary fluctuation or measurement variability.
6. Can I have depression if my screen was negative?
Yes. A negative screen does not exclude a disorder, especially when persistent symptoms or impairment are present. Ask for clinical evaluation when you have concerns despite the score. AAP GLAD-PC.
7. Can anxiety make a depression screen positive?
Yes. Anxiety and depression can overlap in sleep, attention, energy, and other experiences, and they can occur together. A clinical evaluation considers both and may identify comorbidity. See Anxiety and Depression.
8. Do I have to take antidepressants after a positive score?
No. Medication decisions are made following assessment and shared discussion. The presence of a positive screen alone does not determine whether treatment is required or which treatment fits. NICE NG222.
9. Does a positive screen mean I need a psychiatrist?
Not necessarily. Many people begin with a primary care clinician who evaluates symptoms and determines whether behavioral-health referral is appropriate. More complex symptoms, uncertainty, or safety concerns may justify specialized assessment.
10. What if I answered yes to the self-harm question?
Tell a qualified clinician promptly so that someone can directly assess your safety. The answer is important even if the total score is low. If you may act on suicidal thoughts or cannot remain safe, seek immediate emergency help. NIMH ASQ toolkit.
11. Is screening different from diagnosing depression in teenagers?
Yes. Adolescent screening is a first step; developmental context, direct interview, impairment, safety, and additional information are needed for diagnosis. AAP GLAD-PC.
12. Should I keep my questionnaire results?
Keeping the questionnaire's name, score, date, and any relevant responses can help a clinician interpret the result and compare later measurements. Protect the information as you would other personal health information.
Conclusion
A positive depression screening result is a reason for clinical attention, not a final answer about mental health. It can reveal meaningful symptoms, open access to care, and help decide what further assessment is needed. Its clinical value emerges when the result is interpreted together with duration, functioning, safety, medical context, psychiatric history, and the person's own priorities. A structured, compassionate follow-up is the appropriate response to a positive screen. USPSTF; NICE quality standard.
Related Articles
Depression: Symptoms, Causes, Diagnosis, and Treatment — the overarching guide to depressive disorders and care pathways.
Depression Diagnosis: What a Clinical Evaluation Includes — a detailed examination of diagnostic interviewing and differential assessment.
Depression Symptoms: Emotional, Physical, and Behavioral Signs — learn how depressive symptoms present and affect functioning.
Depression vs Sadness: How to Understand the Difference — compare experiences of low mood and depressive illness.
Depression Treatment: Therapy, Medication, and Other Options — treatment decisions after an appropriate clinical evaluation.
Anxiety and Depression: Why They Commonly Co-Occur — a cross-cluster view of co-occurring conditions.
References
American Academy of Pediatrics. (2024). Suicide and suicide risk in adolescents. Pediatrics, 153(1), e2023064800. Journal article.
Levis, B., Benedetti, A., Thombs, B. D., et al. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). Recommendations.
National Institute for Health and Care Excellence. (2023). Depression in adults: Quality statement 1—Assessment (QS8). Quality standard.
National Institute of Mental Health. (n.d.). Ask Suicide-Screening Questions (ASQ) toolkit. Official clinical toolkit.
National Institute of Mental Health. (n.d.). Depression. Official health publication.
U.S. Department of Veterans Affairs & Department of Defense. (2022). VA/DoD clinical practice guideline for the management of major depressive disorder. Guideline repository.
U.S. Preventive Services Task Force. (2023). Depression and suicide risk in adults: Screening. Recommendation statement.
U.S. Preventive Services Task Force. (2023). Depression and suicide risk in adults: Screening—Final evidence summary. Systematic evidence review.
Zuckerbrot, R. A., Cheung, A., Jensen, P. S., Stein, R. E. K., Laraque, D., & GLAD-PC Steering Group. (2018; reaffirmed 2025). Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Pediatrics, 141(3), e20174081. https://doi.org/10.1542/peds.2017-4081.